These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21303546)

  • 1. Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency.
    Yuan X; Lin X; Manorek G; Howell SB
    BMC Cancer; 2011 Feb; 11():61. PubMed ID: 21303546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors.
    Yuan X; Lin X; Manorek G; Kanatani I; Cheung LH; Rosenblum MG; Howell SB
    Mol Cancer Ther; 2009 Jul; 8(7):1906-15. PubMed ID: 19567823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
    Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
    Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
    Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
    Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin.
    Ebihara C; Kondoh M; Hasuike N; Harada M; Mizuguchi H; Horiguchi Y; Fujii M; Watanabe Y
    J Pharmacol Exp Ther; 2006 Jan; 316(1):255-60. PubMed ID: 16183701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A claudin 3 and claudin 4-targeted Clostridium perfringens protoxin is selectively cytotoxic to PSA-producing prostate cancer cells.
    Romanov V; Whyard TC; Waltzer WC; Gabig TG
    Cancer Lett; 2014 Sep; 351(2):260-4. PubMed ID: 24952257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
    Pahle J; Menzel L; Niesler N; Kobelt D; Aumann J; Rivera M; Walther W
    BMC Cancer; 2017 Feb; 17(1):129. PubMed ID: 28193196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.
    Litkouhi B; Kwong J; Lo CM; Smedley JG; McClane BA; Aponte M; Gao Z; Sarno JL; Hinners J; Welch WR; Berkowitz RS; Mok SC; Garner EI
    Neoplasia; 2007 Apr; 9(4):304-14. PubMed ID: 17460774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy.
    English DP; Santin AD
    Int J Mol Sci; 2013 May; 14(5):10412-37. PubMed ID: 23685873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
    Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
    Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.
    Sonoda N; Furuse M; Sasaki H; Yonemura S; Katahira J; Horiguchi Y; Tsukita S
    J Cell Biol; 1999 Oct; 147(1):195-204. PubMed ID: 10508866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for
    Vecchio AJ; Rathnayake SS; Stroud RM
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Target-specific cytotoxic activity of recombinant fusion toxin C-CPE-ETA' against CLDN-3,4-overexpressing ovarian cancer cells].
    Yao Q; Zheng QM; Wen JF; Lü T; Wei MQ; Dai SZ
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):897-902. PubMed ID: 21223796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer.
    Cocco E; Casagrande F; Bellone S; Richter CE; Bellone M; Todeschini P; Holmberg JC; Fu HH; Montagna MK; Mor G; Schwartz PE; Arin-Silasi D; Azoudi M; Rutherford TJ; Abu-Khalaf M; Pecorelli S; Santin AD
    BMC Cancer; 2010 Jul; 10():349. PubMed ID: 20598131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor effect of a recombinant Bifidobacterium strain secreting a claudin-targeting molecule in a mouse breast cancer model.
    Shimizu Y; Isoda K; Taira Y; Taira I; Kondoh M; Ishida I
    Eur J Pharmacol; 2020 Nov; 887():173596. PubMed ID: 32979353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
    Casagrande F; Cocco E; Bellone S; Richter CE; Bellone M; Todeschini P; Siegel E; Varughese J; Arin-Silasi D; Azodi M; Rutherford TJ; Pecorelli S; Schwartz PE; Santin AD
    Cancer; 2011 Dec; 117(24):5519-28. PubMed ID: 21692061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin.
    Li X; Saeki R; Watari A; Yagi K; Kondoh M
    Eur J Pharm Sci; 2014 Feb; 52():132-7. PubMed ID: 24231339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein.
    Fujita K; Katahira J; Horiguchi Y; Sonoda N; Furuse M; Tsukita S
    FEBS Lett; 2000 Jul; 476(3):258-61. PubMed ID: 10913624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin.
    Robertson SL; Smedley JG; McClane BA
    Infect Immun; 2010 Jan; 78(1):505-17. PubMed ID: 19884339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photochemical activation of the recombinant HER2-targeted fusion toxin MH3-B1/rGel; Impact of HER2 expression on treatment outcome.
    Bull-Hansen B; Cao Y; Berg K; Skarpen E; Rosenblum MG; Weyergang A
    J Control Release; 2014 May; 182():58-66. PubMed ID: 24637464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.